Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Sales (2020 - 2025)

Historic Return on Sales for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to 32.27%.

  • Pliant Therapeutics' Return on Sales changed N/A to 32.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 72.43%, marking a year-over-year change of. This contributed to the annual value of 102.11% for FY2023, which is 893800.0% down from last year.
  • Latest data reveals that Pliant Therapeutics reported Return on Sales of 32.27% as of Q3 2025.
  • Pliant Therapeutics' Return on Sales' 5-year high stood at 70.3% during Q1 2025, with a 5-year trough of 688.48% in Q1 2024.
  • Over the past 5 years, Pliant Therapeutics' median Return on Sales value was 17.32% (recorded in 2022), while the average stood at 61.99%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -6602900bps in 2024, then surged by 7587800bps in 2025.
  • Pliant Therapeutics' Return on Sales (Quarter) stood at 12.27% in 2021, then crashed by -45bps to 17.84% in 2022, then crashed by -472bps to 102.11% in 2023, then crashed by -574bps to 688.48% in 2024, then surged by 105bps to 32.27% in 2025.
  • Its Return on Sales was 32.27% in Q3 2025, compared to 53.52% in Q2 2025 and 70.3% in Q1 2025.